205 related articles for article (PubMed ID: 37424693)
1. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation.
Zhang S; Wang C; Liu B; Lu QB; Shang J; Zhou Y; Jia J; Xu X; Rao H; Han B; Zhao T; Chen L; Xie M; Cui J; Du J; Zeng J; Huang N; Liu Y; Zhang L; Zhuang H; Cui F
Lancet Reg Health West Pac; 2023 Jun; 35():100738. PubMed ID: 37424693
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
3. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
4. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
5. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
Brahmania M; Lombardero M; Hansen BE; Terrault NA; Lok AS; Perrillo RP; Belle SH; Di Bisceglie AM; Feld JJ; Lee WM; Fried MW; Janssen HLA;
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2541-2551.e2. PubMed ID: 30743006
[TBL] [Abstract][Full Text] [Related]
6. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.
Zheng Y; Wu J; Ding C; Xu K; Yang S; Li L
Virol J; 2020 Aug; 17(1):132. PubMed ID: 32859216
[TBL] [Abstract][Full Text] [Related]
7. Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide.
Zhang L; Liu H; Zou Z; Su S; Ong JJ; Ji F; Cui F; Chan PL; Ning Q; Li R; Shen M; Fairley CK; Liu L; Seto WK; Wong WCW
Lancet Reg Health West Pac; 2023 Jun; 35():100737. PubMed ID: 37424676
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
11. Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model.
Zu J; Li M; Zhuang G; Liang P; Cui F; Wang F; Zheng H; Liang X
Medicine (Baltimore); 2018 Apr; 97(16):e0484. PubMed ID: 29668627
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea.
Lee D; Shin HY; Park SM
Cost Eff Resour Alloc; 2018; 16():6. PubMed ID: 29467596
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective study on the liver pathological characteristics and the effect of antiviral treatment for 1 to 7 years old children with heptitis B e antigen negative chronic hepatitis B].
Zhu SS; Dong Y; Wang LM; Xu ZQ; Chen DW; Gan Y; Wang FC; Yan JG; Cao LL; Wang P; Zhang M; Zhang HF
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):587-91. PubMed ID: 27510870
[TBL] [Abstract][Full Text] [Related]
14. Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008-2012: A cross-sectional study.
Chevaliez S; Roudot-Thoraval F; Brouard C; Gordien E; Zoulim F; Brichler S; Brodard V; Pioche C; Pawlotsky JM; Leroy V;
JHEP Rep; 2022 Dec; 4(12):100593. PubMed ID: 36313185
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
16. Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China.
Liu W; Zhuang T; Xia R; Zou Z; Zhang L; Shen M; Zhuang G
BMC Public Health; 2022 Jun; 22(1):1179. PubMed ID: 35698098
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
[No Abstract] [Full Text] [Related]
18. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
[No Abstract] [Full Text] [Related]
19. Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies.
Li R; Shen M; Ong JJ; Cui F; Hu W; Chan P; Zou Z; Su S; Liu H; Zhang L; Seto WK; Wong WCW
JHEP Rep; 2023 Oct; 5(10):100833. PubMed ID: 37675271
[TBL] [Abstract][Full Text] [Related]
20. Costs and health impact of delayed implementation of a national hepatitis B treatment program in China.
Toy M; Hutton D; Jia J; So S
J Glob Health; 2022 Jul; 12():04043. PubMed ID: 35796158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
